연구
연구업적
최근 5년 연구업적 현황
| 연도 | 2025년 | 2024년 | 2023년 | 2022년 | 2021년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 196편 | 179편 | 173편 | 163편 | 184편 |
| 공동 | 132편 | 147편 | 120편 | 115편 | 136편 | |
| 합계 | 328편 | 326편 | 293편 | 278편 | 320편 | |
3125. Whole-Genome Sequencing Reveals Mutational Signatures Related to Radiation-Induced Sarcomas and DNA-Damage-Repair Pathways
Kim E, Han DJ, Kim BH, Yoo J, Kim HJ, Wu HG, Kim KS, Kim HS, Han I, Moon KC, Park JH, Song S, Kim TM, Chang JH
Mod Pathol. 2023 Jan;36(1):100004
Link
3124. Treatment outcomes of stereotactic body radiation therapy for pulmonary metastasis from sarcoma: a multicenter, retrospective study
Lee TH, Kim HJ, Kim JH, Kim MS, Jang WI, Kim E, Kim KS
Radiat Oncol. 2023 Apr 15;18(1):68
Link
3123. Practical Utility of Liquid Biopsies for Evaluating Genomic Alterations in Castration-Resistant Prostate Cancer.
Jeong SH, Kyung D, Yuk HD, Jeong CW, Lee W, Yoon JK, Kim HP, Bang D, Kim TY, Lim Y, Kwak C.
Cancers (Basel)
2023 May 20;15(10):2847.
Link
3122. Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR- or ALK-Mutated Non-Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04)
Sehhoon Park 1, Tae Min Kim 2, Ji-Youn Han 3, Gyeong-Won Lee 4, Byoung Yong Shim 5, Yun-Gyoo Lee 6, Sang-We Kim 7, Il Hwan Kim 8, Suee Lee 9, Yu Jung Kim 10, Ji Hyun Park 11, Sang-Gon Park 12, Ki Hyeong Lee 13, Eun Joo Kang 14, Ju Won Kim 15, Seong-Hoon Shin 16, Chan-Young Ock 17, Byung-Ho Nam 18, Jaebong Lee 19, Hyun-Ae Jung 1, Jong-Mu Sun 1, Se-Hoon Lee 1, Jin Seok Ahn 1, Myung-Ju Ahn 1
J Clin Oncol
. 2023 Oct 20:JCO2301891.
Link
3121. Multi-targeted therapy resistance via drug-induced secretome fucosylation
Mark Borris D Aldonza # 1 2 3 4 5, Junghwa Cha # 6, Insung Yong 6, Jayoung Ku 1, Pavel Sinitcyn 7, Dabin Lee 4 5, Ryeong-Eun Cho 1, Roben D Delos Reyes 8, Dongwook Kim 3 5, Soyeon Kim 9 10, Minjeong Kang 1, Yongsuk Ku 1, Geonho Park 1, Hye-Jin Sung 3 5, Han Suk Ryu 11, Sukki Cho 12, Tae Min Kim 9 10, Pilnam Kim # 6 13, Je-Yoel Cho # 3 4 5, Yoosik Kim # 1 13 14 15
Elife
. 2023 Mar 24:12:e75191.
Link
3120. Intrathoracic Progression is Still the Most Dominant Failure Pattern after First-line Chemo-immunotherapy in Extensive-stage Small-Cell Lung Cancer: Implications for Thoracic Radiotherapy
Dowook Kim 1 2, Hak Jae Kim 2 3 4, Hong-Gyun Wu 2 3 4, Joo Ho Lee 2 4, Suzy Kim 2 5, Tae Min Kim 3 6, Jin-Soo Kim 7, Byoung Hyuck Kim 2 5
Cancer Res Treat
. 2023 Nov 6
Link
3119. Facial Cutaneous Rosai-Dorfman Disease: Dermoscopic Findings with Successful Surgical Treatment
Keunyoung Hur 1, Ji Yeon Hong 1, Kyu Han Kim 1, Jihui Jeon 2, Cheol Lee 3, Yoonjin Kwak 3, Tae Min Kim 4, Je-Ho Mun 5
Ann Dermatol
. 2023 Nov;35(Suppl 2):S287-S291
Link
3118. Deep learning based on dynamic susceptibility contrast MR imaging for prediction of local progression in adult-type diffuse glioma (grade 4)
Donggeon Heo # 1, Jisoo Lee # 1, Roh-Eul Yoo 2 3, Seung Hong Choi 4 5 6 7, Tae Min Kim 8, Chul-Kee Park 9, Sung-Hye Park 10, Jae-Kyung Won 10, Joo Ho Lee 11, Soon Tae Lee 12, Kyu Sung Choi 13, Ji Ye Lee 13, Inpyeong Hwang 13, Koung Mi Kang 13, Tae Jin Yun 13
Sci Rep
. 2023 Aug 24;13(1):13864.
Link
3117. A multicenter, phase II trial of GC1118, a novel anti-EGFR antibody, for recurrent glioblastoma patients with EGFR amplification
Seung Won Choi 1, Hyun Ae Jung 2, Hee-Jin Cho 3, Tae Min Kim 4, Chul-Kee Park 5, Do-Hyun Nam 1, Se-Hoon Lee 2
Cancer Med
. 2023 Aug;12(15):15788-15796
Link
3116. Concomitant ruxolitinib with
cytarabine-based induction
chemotherapy in secondary acute
myeloid leukemia evolving from
myeloproliferative neoplasm
Dong Hyun Kim1, Ja Min Byun1,2, Dong-Yeop Shin1,2,3,4,
Inho Kim1,2,3,4, Sung-Soo Yoon1,2,3,4, Youngil Koh1,2,3,4
Blood Res
. 2023 Sep 30;58(3):155-157.
Link